Global Industry Analysts (GIA) has released a global report on the biotechnology instrumentation markets that predicts that it will reach $5.8 billion by the year 2015.
Global Industry Analysts (GIA) has released a global report on the biotechnology instrumentation markets that predicts that it will reach $5.8 billion by the year 2015. According to the report, this is driven by growth in drug discovery research, advancements in DNA sequencing technology and growing demand for the instrumentation from food, environmental, life science, material and chemical industries.
The US represents the largest regional market for biotechnology instrumentation worldwide, with Europe second. Asia Pacific is projected to record the fastest growth over the analysis period, driven by expansion of the Indian and Chinese economies, coupled with a shift into high-technology arenas such as biotechnology, speciality chemicals, electronics, pharmaceuticals and steel.
Universities, particularly medical schools, are reported to be the largest end-users of biotech instruments, while product enhancements, such as automation and better reproducibility, have led to an increased demand from pharmaceutical companies. The use of bioinstrumentation techniques has become simple and more accessible and the routine biological tests in forensic laboratories and food technology facilities are now performed by instruments such as off-the-shelf kits of PCR primers, automated analytical equipment and automated synthesizers.
Rapid advancements in biotechnology and pharmaceutical research require complicated analysis and purification methods. Increased interest in these fields is reported to have led to a significant increase in the use of analytical techniques such as HPLC, gas chromatography and mass spectrometry.
Segment wise, HPLC equipment and supplies are reported to represent the largest product segment. The ongoing advancements including hyphenation with mass spectrometry and automation of HPLC systems are expected to support market demand in the future. Fastest growth is reported in the electrophoresis equipment and supplies market.
For more details about this comprehensive market research report titled “Biotechnology Instrumentation: A Global Strategic Business Report”, please visit http://www.strategyr.com/Biotechnology_Instrumentation_Market_Report.asp
Advancing Bladder Cancer Research with Mass Spectrometry: A FeMS Interview with Marta Relvas-Santos
November 12th 2024LCGC International interviewed FeMS Empowerment Award winner Marta Relvas-Santos on her use of mass spectrometry to identify potential biomarkers and therapies for bladder cancer. She also shared insights on her work with FeMS and advice for fellow scientists.
Exploring The Chemical Subspace of RPLC: A Data-driven Approach
November 11th 2024Saer Samanipour from the Van ‘t Hoff Institute for Molecular Sciences (HIMS) at the University of Amsterdam spoke to LCGC International about the benefits of a data-driven reversed-phase liquid chromatography (RPLC) approach his team developed.